Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Doshi

Showing results (51-60 of 52) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 52 results.
Indian Journal of Cancer|March 1, 2017
Weekly cisplatin (30-40 mg/m<sup>2</sup>) as radiosensitizer: Is it high or moderate emetic agent?A Karpe, V M Patil, A Joshi, et al.
Journal of Medical Systems|May 19, 2006
Enhancing the utility of prostascint SPECT scans for patient managementMarilyn E Noz, Grace Chung, Benjamin Y Lee, et al.
Pageof 6

Showing results (51-60 of 52) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 52 results.
Indian Journal of Cancer|March 1, 2017
Weekly cisplatin (30-40 mg/m<sup>2</sup>) as radiosensitizer: Is it high or moderate emetic agent?A Karpe, V M Patil, A Joshi, et al.
Journal of Medical Systems|May 19, 2006
Enhancing the utility of prostascint SPECT scans for patient managementMarilyn E Noz, Grace Chung, Benjamin Y Lee, et al.
Pageof 6